RenovoRx Appoints Margaret A. Tempero, M.D., to Scientific Advisory Board
RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing targeted combination therapies, today announced the appointment of Margaret A. Tempero, M.D., Director, UCSF Pancreas Center... | June 20, 2023